EA
AMED

Emerald Acquisition’s Amedisys AMED Stock Holding History

Emerald Acquisition’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$3.6M Sell
75,917
-139,784
-65% -$6.98M 0.01% 1410
2016
Q2 		$10.9M Buy
+215,701
New +$10.9M 0.02% 894

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Emerald Acquisition's AMED Position: Q3 2016 in Review

Emerald Acquisition reduced its Amedisys (AMED) stake by 65% in Q3 2016, selling an estimated $6.98M and leaving 75,917 shares worth $3.6M. The position accounts for 0.01% of the portfolio, ranked #1410.

Emerald Acquisition first reported a position in AMED in Q2 2016 and has held it in 2 quarters since. The position peaked at $10.9M in Q2 2016. 153 funds tracked by Wall St. Rank hold AMED as of Q3 2016.

  • Emerald Acquisition held 75,917 shares of Amedisys worth $3.6M as of Q3 2016.
  • Emerald Acquisition sold 139,784 Amedisys shares in Q3 2016, an estimated $6.98M.
  • Amedisys made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1410 holding.
  • Emerald Acquisition first reported a position in Amedisys in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Amedisys position peaked at $10.9M in Q2 2016.
  • 153 funds tracked by Wall St. Rank held Amedisys as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.